Invivyd, Inc. - Common Stock (NQ:IVVD)

1.775 +0.035 (+2.01%)

Streaming Delayed Price Updated: 10:15 AM EDT, Mar 16, 2026 Add to My Watchlist

Price and Volume

Volume	432,487
Open	1.790
Bid (Size)	1.770 (1,000)
Ask (Size)	1.780 (700)
Prev. Close	1.740
Today's Range	1.760 - 1.830
52wk Range	0.4600 - 3.070
Shares Outstanding	109,755,624
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

March 09, 2026

U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-market trading after reporting fourth-quarter results. Other stocks declining in pre-market trading...

Via Benzinga

Invivyd (IVVD) Q4 2025 Earnings Call Transcript ↗

March 05, 2026

Invivyd (IVVD) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Performance

YTD	-29.0%	-29.0%
1 Month	+13.8%	+13.8%
3 Month	-20.0%	-20.0%
6 Month	+38.7%	+38.7%
1 Year	+132.3%	+132.3%

More News

Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates

March 05, 2026

From Invivyd

Via GlobeNewswire

Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer

March 05, 2026

From Invivyd

Via GlobeNewswire

Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026

March 02, 2026

From Invivyd

Via GlobeNewswire

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 02, 2026

From Invivyd

Via GlobeNewswire

New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies

February 24, 2026

From Invivyd

Via GlobeNewswire

Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration

February 03, 2026

From Invivyd

Via GlobeNewswire

Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention

January 22, 2026

From Invivyd

Via GlobeNewswire

Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026

January 20, 2026

From Invivyd

Via GlobeNewswire

Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights

January 08, 2026

From Invivyd

Via GlobeNewswire

Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

December 23, 2025

From Invivyd

Via GlobeNewswire

Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

December 23, 2025

From Invivyd

Via GlobeNewswire

Invivyd to Participate at the 8th Annual Evercore Healthcare Conference

November 25, 2025

From Invivyd

Via GlobeNewswire

Invivyd Inc (NASDAQ:IVVD) Emerges as High-Growth Momentum Leader ↗

November 24, 2025

Via Chartmill

Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness

November 24, 2025

From Invivyd

Via GlobeNewswire

These stocks that are showing activity before the opening bell on Tuesday. ↗

November 18, 2025

Via Chartmill

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 18, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 18, 2025

Via Benzinga

Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

November 18, 2025

Via Benzinga

Invivyd Stock Hits 19-Month High As Public Offering Lands Days After Point72, Janus Henderson Reveal Big Stakes ↗

November 17, 2025

Via Stocktwits

Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants

November 17, 2025

From Invivyd

Via GlobeNewswire

What's going on in today's after hours session ↗

November 17, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 17, 2025

Via Benzinga

Invivyd Announces Proposed Public Offering of Common Stock

November 17, 2025

From Invivyd

Via GlobeNewswire

Frequently Asked Questions

Is Invivyd, Inc. - Common Stock publicly traded?

Yes, Invivyd, Inc. - Common Stock is publicly traded.

What exchange does Invivyd, Inc. - Common Stock trade on?

Invivyd, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Invivyd, Inc. - Common Stock?

The ticker symbol for Invivyd, Inc. - Common Stock is IVVD on the Nasdaq Stock Market

What is the current price of Invivyd, Inc. - Common Stock?

The current price of Invivyd, Inc. - Common Stock is 1.775

When was Invivyd, Inc. - Common Stock last traded?

The last trade of Invivyd, Inc. - Common Stock was at 03/16/26 10:15 AM ET

What is the market capitalization of Invivyd, Inc. - Common Stock?

The market capitalization of Invivyd, Inc. - Common Stock is 194.82M

How many shares of Invivyd, Inc. - Common Stock are outstanding?

Invivyd, Inc. - Common Stock has 195M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.